J H Hendry

发表

Workshop report: future directions for predictive assays, 25-27 March 1993, Round Top, Texas.

N H Terry, W A Brock, J H Hendry, 1993, International journal of radiation biology.

The tissue-rescuing unit.

J H Hendry, J. Hendry, H D Thames, 1986, The British journal of radiology.

Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines

J H Hendry, J. Hendry, C. Herring, 1999, British Journal of Cancer.

Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms.

C J Moore, J H Hendry, R I MacKay, 1997, The British journal of radiology.

Development of synthetic promoters for radiation-mediated gene therapy

J H Hendry, J. Hendry, G. Margison, 2000, Gene Therapy.

Intestinal crypt clonogens: a new interpretation of radiation survival curve shape and clonogenic cell number

J H Hendry, J. Hendry, C. Potten, 2003, Cell proliferation.

Can modest escalations of dose be detected as increased tumor control?

T E Schultheiss, W A Brock, J H Hendry, 1992, International journal of radiation oncology, biology, physics.

A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity.

J H Hendry, J. Hendry, S. Roberts, 1998, International journal of radiation oncology, biology, physics.

Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.

J H Hendry, J. Hendry, S. Roberts, 1999, International journal of radiation oncology, biology, physics.

The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and units.

J H Hendry, P Andreo, A Wambersie, 2006, Radiation protection dosimetry.

Deduction of the clonogen content of intestinal crypts: a direct comparison of two-dose and multiple-dose methodologies.

J H Hendry, J. Hendry, S. Roberts, 1995, Radiation research.

Intrinsic radiosensitivity as a predictor of patient response to radiotherapy.

J H Hendry, J. Hendry, C M West, 1992, BJR supplement.

The intrinsic radiosensitivity of normal and tumour cells.

J H Hendry, J. Hendry, S. Roberts, 1998, International journal of radiation biology.

The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.

J H Hendry, R I Mackay, J. Hendry, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypofractionation for prostate cancer.

J H Hendry, J P Logue, J. Hendry, 2001, International journal of radiation oncology, biology, physics.

Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues.

J H Hendry, J. Hendry, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context

J H Hendry, F. Stewart, J. Hendry, 2012, Annals of the ICRP.